Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 09, 2006 08:29 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals to Present at the 5th Annual North America Forum for Investing and Partnering in Biotech and Medtech

NEW YORK, March 9, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) announced today that Douglas Abel, President and Chief Executive Officer, will present at the 5th Annual North America...
February 10, 2006 11:09 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals' President and CEO Named Panelist for Obesity Focus Session at BIO CEO & Investor Conference

NEW YORK, Feb. 10, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) announced today that Douglas Abel, president and chief executive officer, will be a panelist for the "Obesity:...
February 01, 2006 08:29 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals Names Alan Harris Chief Medical Officer

NEW YORK, Feb. 1, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) announced that Alan G. Harris, MD, PhD has been named Chief Medical Officer of the company. Dr. Harris brings more...
December 28, 2005 08:29 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals' Topical Psoriasis Treatment in Phase IIa Trial

NEW YORK, Dec. 28, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) reported that a Phase IIa study has been initiated with PTH (1-34), its experimental product for the topical...
November 03, 2005 08:29 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference

NEW YORK, Nov. 3, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, the Company's President and Chief Executive Officer, will give a presentation on...
October 25, 2005 16:24 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals Chief Reviews Obesity Drug Candidate at New York Investment Conference

NEW YORK, Oct. 25, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals Inc.'s (AMEX:MHA) Chief Executive Officer Douglas Abel said preliminary data from a small Phase I study of the company's experimental...
October 25, 2005 08:29 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals to Present At the PIPEs Conference 2005 In New York

NEW YORK, Oct. 25, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) announced that Douglas Abel, President and Chief Executive Officer, will present at the PIPEs Conference 2005 on...
October 20, 2005 08:29 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals to Present at C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference

NEW YORK, Oct. 20, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) will be presenting at the C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference on Tuesday, October 25th at...
October 17, 2005 09:42 ET | Source: Manhattan Pharmaceuticals, Inc.

CORRECTING and REPLACING -- Manhattan Pharmaceuticals Presents Preliminary Phase I Results of Experimental Obesity Drug

NEW YORK, Oct. 17, 2005 (PRIMEZONE) -- A Manhattan Pharmaceuticals, Inc. (AMEX:MHA) news release issued today at 7:44 a.m. (ET) (Oct. 17, 2005) contained errors in the table of VAS scores. The...
October 17, 2005 07:44 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals Presents Preliminary Phase I Results of Experimental Obesity Drug

NEW YORK, Oct. 17, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) announced preliminary results from two Phase I clinical trials of oleoyl-estrone (OE), an experimental, orally...